https://orcid.org/0000-0003-3936-9078
References
- Aghssa, M. M., Tarafdari, A. M., Tehraninejad, E. S., Ezzati, M., Bagheri, M., Panahi, Z., Mahdavi, S., & Abbasi, M. (2015). Optimal cutoff value of basal anti-mullerian hormone in Iranian infertile women for prediction of ovarian hyper-stimulation syndrome and poor response to stimulation. Reproductive Health, 12(1), 85. https://doi.org/https://doi.org/10.1186/s12978-015-0053-4
- Al-Inany, H. G., Youssef, M. A., Ayeleke, R., Brown, J., Lam, W., & Broekmans, F. J. (2016). Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. The Cochrane Database of Systematic Reviews, 4(4), CD001750. https://doi.org/https://doi.org/10.1002/14651858.CD001750.pub4
- Broer, S. L., Dólleman, M., van Disseldorp, J., Broeze, K. A., Opmeer, B. C., Bossuyt, P. M., Eijkemans, M. J., Mol, B. W., & Broekmans, F. J. (2013). Prediction of an excessive response in in vitro fertilization from patient characteristics and ovarian reserve tests and comparison in subgroups: an individual patient data meta-analysis. Fertility and Sterility, 100(2), 420–429.e7. https://doi.org/https://doi.org/10.1016/j.fertnstert.2013.04.024
- Delvigne, A. (2009). Symposium: update on prediction and management of OHSS. Reproductive Biomedicine Online, 19(1), 8–13. https://doi.org/https://doi.org/10.1016/S1472-6483(10)60040-5
- Jayaprakasan, K., Chan, Y., Islam, R., Haoula, Z., Hopkisson, J., Coomarasamy, A., & Raine-Fenning, N. (2012). Prediction of invitro fertilization outcome at different antral follicle count thresholds in a prospective cohort of 1,012 women. Fertility and Sterility, 98(3), 657–663. https://doi.org/https://doi.org/10.1016/j.fertnstert.2012.05.042
- Magnusson, Å., Källen, K., Thurin-Kjellberg, A., & Bergh, C. (2018). The number of oocytes retrieved during IVF: a balance between efficacy and safety. Human. Reproduction, 33(1), 58–64. https://doi.org/https://doi.org/10.1093/humrep/dex334
- Mathur, R. S., Akande, A. V., Keay, S. D., Hunt, L. P., & Jenkins, J. M. (2000). Distinction between early and late ovarian hyperstimulation syndrome. Fertility and Sterility, 73(5), 901–907. https://doi.org/https://doi.org/10.1016/S0015-0282(00)00492-1
- Ocal, P., Sahmay, S., Cetin, M., Irez, T., Guralp, O., & Cepni, I. (2011). Serum anti-Müllerian hormone and antral follicle count as predictive markers of OHSS in ART cycles. Journal of Assisted Reproduction and Genetics, 28(12), 1197–1203. https://doi.org/https://doi.org/10.1007/s10815-011-9627-4
- Polyzos, N. P., Tournaye, H., Guzman, L., Camus, M., & Nelson, S. M. (2013). Predictors of ovarian response in women treated with corifollitropin alfa for in vitro fertilization/intracytoplasmic sperm injection. Fertility and Sterility, 100(2), 430–437. https://doi.org/https://doi.org/10.1016/j.fertnstert.2013.04.029
- Rahav Koren, R., Gonen, O., Hershko Klement, A., Haikin Herzberger, E., Ghetler, Y., Shulman, A., & Wiser, A. (2018). Number of oocytes retrieved as a criterion for “freeze-all” strategy versus a single “rescue” bolus of low-dose human chorionic gonadotropin following gnrh agonist for ovulation triggering: a pilot study. Gynecologic and Obstetric Investigation, 83(5), 471–476. https://doi.org/https://doi.org/10.1159/000479557
- Roque, M., Haahr, T., Geber, S., Esteves, S. C., & Humaidan, P. (2019). Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes. Human Reproduction Update, 25(1), 2–14. https://doi.org/https://doi.org/10.1093/humupd/dmy033
- Royal College of Obstetricians and Gynaecologists (RCOG). (2016). The management of Ovarian hyperstimulation syndrome green-top guideline No.5. Royal College of Obstetricians and Gynaecologists, 2016(5), 1–22. Retrieved from https://www.rcog.org.uk/globalassets/documents/guidelines/green-top-guidelines/gtg_5_ohss.pdf
- Salmassi, A., Mettler, L., Hedderich, J., Jonat, W., Deenadayal, A., von Otte, S., Eckmann-Scholz, C., & Schmutzler, A. G. (2015). Cut-off levels of anti-mullerian hormone for the prediction of Ovarian response, in vitro fertilization outcome and ovarian hyperstimulation syndrome. International Journal of Fertility & Sterility, 9(2), 157–167. https://doi.org/https://doi.org/10.22074/ijfs.2015.4236
- The ESHRE Guideline Group on Ovarian Stimulation, Bosch, E., Broer, S., Griesinger, G., Grynberg, M., Humaidan, P., Kolibianakis, E., Kunicki, M., La Marca, A., Lainas, G., Le Clef, N., Massin, N., Mastenbroek, S., Polyzos, N., Sunkara, S. K., Timeva, T., Töyli, M., Urbancsek, J., Vermeulen, N., & Broekmans, F. (2020). ESHRE guideline: Ovarian stimulation for IVF/ICSI†. Human Reproduction Open, 2020(2), hoaa009. https://doi.org/https://doi.org/10.1093/hropen/hoaa009
- Verwoerd, G. R., Mathews, T., & Brinsden, P. R. (2008). Optimal follicle and oocyte numbers for cryopreservation of all embryos in IVF cycles at risk of OHSS. Reproductive Biomedicine Online, 17(3), 312–317. https://doi.org/https://doi.org/10.1016/S1472-6483(10)60213-1
- Youssef, M. A., Van der Veen, F., Al-Inany, H. G., Mochtar, M. H., Griesinger, G., Nagi Mohesen, M., Aboulfoutouh, I., & van Wely, M. (2014). Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist-assisted reproductive technology. The Cochrane Database of Systematic Reviews, 2014(10), CD008046. https://doi.org/https://doi.org/10.1002/14651858.CD008046.pub4